← Back to Clinical Trials
Recruiting NCT06869694

NCT06869694 Energy CT in Imaging and Diagnosis of Gastric Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06869694
Status Recruiting
Phase
Sponsor The First Affiliated Hospital of Zhengzhou University
Condition Gastric Cancer
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2024-09-01
Primary Completion 2026-09-01

Trial Parameters

Condition Gastric Cancer
Sponsor The First Affiliated Hospital of Zhengzhou University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-01
Completion 2026-09-01
All Conditions
Interventions
computerized tomography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Accurate preoperative prediction of risk stratification, treatment response, and survival prognosis in gastric cancer is important for improving clinical treatment decisions, prolonging patient survival, and improving patient quality of life. The purpose of this study is to investigate the performance of the multi-parametric magnetic resonance imaging (mpMRI) and Dual-/Muti-energy CT and photon-counting Detector CT(PCD-CT) in the diagnosis and management of gastric cancer.

Eligibility Criteria

Inclusion Criteria: 1. Pathological biopsy confirmed gastric cancer; 2. Surgery: patients undergoing radical gastrectomy. Patients undergoing exploratory abdominal surgery or palliative tumor resection were still included in the study when peritoneal metastasis or adjacent organ invasion was identified intraoperatively and radical surgical resection was not possible. Exclusion Criteria: 1. Refusal or inability to sign informed consent; 2. CT or MRI images are poor or the focus is small and CT images are not clear; 3. Patients with other tumors complicated with patients with important organ dysfunction.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology